Visual information is conveyed from the eye to the brain by distinct types of retinal ganglion cells (RGCs). It is largely unknown how RGCs acquire their defining morphological and physiological features and connect to upstream and downstream synaptic partners. The three Brn3/Pou4f transcription factors (TFs) participate in a combinatorial code for RGC type specification, but their exact molecular roles are still unclear. We use deep sequencing to define (i) transcriptomes of Brn3a-and/or Brn3b-positive RGCs, (ii) Brn3a-and/or Brn3b-dependent RGC transcripts, and (iii) transcriptomes of retinorecipient areas of the brain at developmental stages relevant for axon guidance, dendrite formation, and synaptogenesis. We reveal a combinatorial code of TFs, cell surface molecules, and determinants of neuronal morphology that is differentially expressed in specific RGC populations and selectively regulated by Brn3a and/or Brn3b. This comprehensive molecular code provides a basis for understanding neuronal cell type specification in RGCs.
T he molecular analysis of neuronal circuits benefits significantly from modern approaches to gene expression profiling and genetic manipulation. The mechanisms of cell type specification are still poorly understood, but experiments in model organisms suggest a combination of transcriptional regulation, extracellular signals, and cell-cell interactions (1) (2) (3) (4) . Retinal ganglion cells (RGCs) are a particularly powerful system for illustrating the molecular and activity-dependent mechanisms of cell type specification. Based on molecular markers, dendritic arbor morphologies, axonal projections to retinorecipient areas of the brain, synaptic partners, physiological properties, and roles within the visual circuit, mouse RGCs can be cataloged in 20-30 different types (5) (6) (7) (8) (9) (10) . Some of the developmental mechanisms by which RGC features are combined to determine RGC types are beginning to be uncovered. Mouse RGCs become postmitotic and start exhibiting specific molecular markers and morphological features around embryonic day 11 (E11). As soon as E12, RGC axons cross the midline at the optic chiasm, and by E15, the first axons have reached the superior colliculus (SC), the most remote retinorecipient area of the brain (11, 12) . RGC axons invade their target nuclei only around birth, and the first 10 postnatal days are the most active period for synapse formation. RGC dendritic arbors develop mostly postnatally, with lamination within the inner plexyform layer clearly visible at postnatal days 3-4 (P3-P4) and reaching a nearly mature distribution by P7 (13) (14) (15) (16) . Combinatorial transcriptional regulation may play a major role in RGC type specification. Previous work suggests the following transcriptional cascade: the basic helix-loop-helix (bHLH) transcription factor (TF) Atoh7 is expressed in RGC precursors and controls the expression of the POU4 family TF Brn3b and the Lim domain TF Isl1, which are both required for the initiation of the RGC transcriptional program (17) (18) (19) (20) (21) (22) (23) (24) (25) . Further downstream TFs include Brn3a, Brn3c, Eomesodesmin (Tbr2), Ebf1, Ebf3, Onecut1, and Onecut2 (6, 13, (26) (27) (28) (29) (30) (31) (32) (33) . Together with Isl1 and Brn3b, these downstream factors are expressed in partially overlapping patterns in RGC types, and some were shown to be required for survival and/or dendrite and axon formation in various RGC types. However, many other TFs may be involved in generating the diversity of RGC types (34) (35) (36) (37) (38) . We have previously used reporter knock-in alleles expressing alkaline phosphatase (AP; a glycosylphosphatidylinositol (GPI)-linked, extracellular molecule) at the loci of Brn3a, Brn3b, and Brn3c (Brn3 CKOAP ) to describe their cell type distribution among RGCs and other sensory projection neurons. We also identified axonal and dendrite arbor defects in RGCs missing Brn3a, Brn3b, or Brn3c either alone or in combination (6, 13, 31, 39, 40) . We now describe an immunoaffinity purification strategy using anti-AP antibodies to isolate RGCs from Brn3 AP RGCs that are either WT or KO for Brn3a or Brn3b. Using our knowledge of partially overlapping RGC populations expressing Brn3s, we can identify molecules selectively enriched in RGCs, selectively expressed in distinct Brn3 RGC subpopulations, and/or regulated by Brn3a or Brn3b in these RGC
Significance
We report here transcriptome analysis by RNA sequencing (RNASeq) of genetically labeled and affinity-purified mouse retinal ganglion cell (RGC) populations. Using a previously established conditional knock-in reporter strategy, we label RGCs from which specific transcription factors have been removed and determine the consequences on transcriptional programs at different stages critical to RGC development. We find that Brn3b and Brn3a control only small subsets of Brn3-RGC-specific transcripts. We identify extensive combinatorial sets of RGC transcription factors and cell surface molecules and show that several RGC-specific genes can induce neurite-like processes cell autonomously in a heterologous system. populations. We focused this study on E15 RGCs to identify axon guidance molecules (Fig. 1A) and P3 RGCs to detect potential determinants for dendrite formation and synaptogenesis (Fig.  1B) . Furthermore, we isolated RNA from retinorecipient areas at P3 to identify differential markers for the cellular targets that might interact with incoming RGC axons (Fig. 1E ). We report a combinatorial code of TFs and cell surface molecules (CSMs) expressed in different RGC subpopulations and retinorecipient areas of the brain. A subset of these genes can intrinsically induce arbor-like processes in epithelial cells, suggesting cellautonomous neuronal arbor formation mechanisms.
Results
Screen Rationale and Sample Collection. We have induced retinaspecific Cre recombination of our conditional knock-in reporter alleles at the Pou4f1 (Brn3a CKOAP ) and Pou4f2 (Brn3b CKOAP ) loci using the Pax6α:Cre driver (13 AP RGCs using magnetic beads coupled to anti-AP mouse mAbs (Materials and Methods and Fig. 1 D and F) . We also have labeled the lateral geniculate nucleus (LGN), SC, and pretectal area (PTA) of P3 WT mice by anterograde tracing and dissected and processed them for deep sequencing (Materials and Methods and Fig. 1E ).
In the following, we will present gene expression data that are restricted to the RefSeq (https://www.ncbi.nlm.nih.gov/refseq/) subset of mouse transcripts given its highest level of quality and annotation confidence (Material and Methods). We use two alternative strategies to identify differentially expressed transcripts in our datasets. The first, differential expression analysis algorithm (DESeq), is the differential expression analysis as described by Anders and Huber (42) , with the false discovery rate set at 0.1 and the fold change at two. The second, referred to in the text as the "Twofold" criterion, identifies a transcript as differentially expressed in a given RGC population if it has expression levels in RGCs more than two fragments per kilobase per million reads (FPKM) and is enriched in RGCs compared with the corresponding retina samples (FPKM levels in Brn3 AP/WT RGCs ≥ 2 × FPKM levels in Brn3 AP/WT retina supernatant). If the transcript also has a more than twofold change between Brn3 AP/WT and Brn3 AP/KO RGCs, it is also considered "regulated" by the respective Brn3.
Deep Sequencing and Sample Quality Control. Because RGCs are a rare retinal cell population (around 0.5%) (43) , bead-coupled RGCs from several mice (typically six to eight retinas) of identical genotype were pooled to constitute one RGC sample. For each genotype described, two RGC samples and one retina supernatant sample were submitted to RNA extraction, reverse transcription, amplification, and sequencing using an Illumina Sequencing platform (Materials and Methods). For WT brain regions, three replicates for LGN and SC (derived each from one mouse) and two replicates for whole-brain homogenates (pooled whole-brain nonvisual regions; each from one mouse) were submitted to sequencing, and one PTA sample was generated by pooling tissues from three individual mice. Correlation coefficients between biological replicates were very high (> 0.95) and between samples (e.g., RGC vs. retina) were lower, ranging from 0.55 to 0.95 ( Fig.  2A , Dataset S2, and Fig. S1A ). Hierarchical clustering across all transcripts expressed in our samples reveals a good correlation of replicates by RGC genotype, retina, age, or brain region ( Fig. 2B and Dataset S3), confirmed also by principal component analysis (Fig. S1 B-D) . We determined the success of our cell purification and deep sequencing strategy in several ways. Visualization of the reads mapping to the endogenous Brn3a and Brn3b loci (Fig. 2 C- (Fig. 2E) . Reads aligned to the AP cDNA [using a "minigenome" generated with Bowtie (44)] (Materials and Methods) display the expected distribution, with essentially no reads in retina samples and high levels of the transcripts in the RGC samples (Fig.  2F ). Of note, in E15 but not P3 RGCs, the AP reporter is expressed at much higher levels in the Brn3b AP/KO than in the Brn3b AP/WT RGCs. Thus, the higher levels of Brn3b reads in the Brn3b KO at E15 could be explained by the AP transcript carrying partial Brn3b 5′ and 3′ UTRs along. Finally, previously described RGC markers are visibly enriched in Brn3 AP RGCs (Fig. 2G) . Thus, we are confident that our cell sorting, RNA isolation, and deep sequencing approach is successful. (Fig. 3A , Dataset S4, and Fig. S1E ). Only a small fraction of these RGC-enriched transcripts seem to be regulated by Brn3b or Brn3a. Strikingly, most of these are selectively affected by Brn3b ablation, and only very few are Brn3a-dependent ( Fig. S1G ). This fact may reflect the distinct RGC-specific programs required at the two ages. The set of Brn3b-dependent genes expressed by Brn3b AP RGCs is also dramatically distinct at the two ages ( Fig. 3 C and D, Dataset S4, and Fig. S1H ). The differences between Brn3a-and Brn3b-positive RGC transcriptomes may reflect differences in cell type distribution, whereas the temporal differences may define the distinct functionality required in the early (E15; axon guidance) vs. late (P3; dendrite formation, synaptogenesis, and myelination) stages of RGC maturation. An analysis of Gene Ontology terms among our candidate genes shows significant enrichment for known neuronalassociated processes and pathways, such as neurotransmitter receptors and release, voltage-gated channels, signaling cascades, synaptic transmission, neuronal projection, etc. Among these pathways, adhesion molecules and TFs represented each about 5-10% of the identified genes, regardless of the selection criteria (Dataset S4).
In Situ Validation. Because the starting RGC population from which RNA was extracted is relatively small and the degree of amplification is quite significant, we sought to validate a subset of about 10% of the identified RGC-enriched molecules with an independent technique. We designed in situ hybridization (ISH) probes for the 3′ UTR of 233 genes from our candidate pool and tested them against WT P3 retinas ( Fig. 3 E, F, and I, Dataset S4, and Fig. S1 I, K, and L). Genes were selected based on literature searches for potentially interesting yet less well-studied pathways related to neuronal development and exhibit a broad range of expression levels. In addition, we searched the Allen Brain Institute mouse brain development ISH atlas (developingmouse. brain-map.org/) with our Brn3b AP/WT RGC E15 candidate gene list and identified 265 genes for which E15 eye sections were available ( Fig. 3 G, H, and J, Dataset S4, and Fig. S1 J, M, and N). There did not seem to be a strong correlation between RNA sequencing (RNASeq) FPKM expression levels and intensity of in situ signal in the ganglion cell layer (GCL) at P3. As an example, in P3 Brn3 AP/WT RGCs, Ig superfamily 6 (Igsf6) is expressed at only 4-7 FPKM, whereas Rab6b has ranges between 150 and 300 FPKM (Fig. 3E) . Whereas both genes are enriched in the GCL, the signal to noise ratio for Igsf6 is much higher than that in Rab6b, although probes are comparable in length and melting temperature. In a similar fashion, Rgs4 and Myt1l have comparable ISH GCL-specific signals at E15 (Fig. 3H) , but Rgs4 has almost six times higher expression in E15 Brn3b AP/WT RGCs compared with Myt1l (75 vs. 13 FPKM). Nevertheless, about 60-75% of candidate genes predicted by RNASeq to be enriched in RGCs over the retina were confirmed by our in situ screens at either P3 or E15. The enrichment with positive hits was not dramatically affected by using either the DESeq or Twofold selection criteria (compare Fig. 3 I and J with Fig. S1 I and J; Dataset S4). Confirmation by ISH was consistently better for Brn3-regulated genes identified by DESeq (Fig. 3 I, Right and J, Right) compared with the Twofold criterion ( Fig. S1 I and J) , but the total number of hits was smaller (Dataset S4). Thus, it seems that DESeq is a more stringent selection method; however, it may miss many useful candidates compared with our Twofold criterion. Overall, more than one-half of the targets identified by deep sequencing show RGC specificity in ISH results, but expression levels detected with the two methods differ significantly.
Retinorecipient Nuclei Transcriptomes and ISH Validation. To identify molecules that may be conferring specificity for the distinct retinorecipient brain areas, we have mined our RNASeq data for transcripts enriched in SC, LGN, or PTA compared with the whole-brain homogenate. Fig. 4 A and B show that essentially all possible combinations can be found, with transcripts common to all three nuclei, common to only two of them, or selective for each nucleus individually (complete lists are in Dataset S5). Of these candidate genes, 122 (LGN), 116 (PTA), and 134 (SC) were tested by ISH by the Allen Brain Institute (examples are in Fig. 4 C-H) . For the LGN and SC, between 55 and 75% of RNASeq-predicted genes were specific or regionally expressed in the expected nucleus, with others being broadly expressed or negative (Fig. 4 I and J) . The number of specific transcripts was much lower for the PTA. Interestingly, several transcripts showed lamination within the SC (Gpc3, Barhl1, and Foxb1), consistent with the possibility that these markers are selective for SC functional laminae (Fig. 4 E and F) . Of note, applying DESeq modestly increased the ratio of positive hits by ISH compared with our Twofold criterion, while reducing the total number of correct hits, similar to what we observed for the RGC data. We, therefore, present throughout the text results based on both selection criteria.
TF Program of Brn3
AP RGCs and Retinorecipient Areas. TFs play a significant role in neuronal cell type diversification. We, therefore, compared our data with a merged list of 2,437 TFs and transcriptional regulation-associated genes compiled by combining recently published surveys (45, 46) . Of these genes, almost one-third (1,647) had expression levels of more than one FPKM in our RGC samples, but a more restricted subset was enriched in RGCs compared with the retina (DESeq = 153, Twofold = 322) (Fig. 5 A, C , and E and Dataset S6 genes was Brn3a-and/or Brn3b-dependent (DESeq = 43, Twofold = 95) (Fig. 5 B, D , and E and Dataset S6). Fig. 5H shows an unsupervised clustering of 38 TFs previously implicated in RGC development. Interestingly, samples are first separated by age (P3 vs. E15) regardless of retina or RGC origin (Fig. 5H , branches a + b vs. c). In addition, at both P3 and E15, Brn3b , and Brn3b AP/WT RGCs at P3). This similarity suggests that loss of Brn3b turns Brn3b AP/KO RGCs into a more undifferentiated "whole-retina" state. When contrasting the horizontal branches of the hierarchical tree, we can distinguish a "general RGC" group (branch 2, Pou4f1, Pou4f2, Irx2, Irx3, Irx4 and Irx6, Ebf1, and Ebf3), a "P3 RGC" group (branch 1, Isl2, Pou4f3, Klf2, Klf8, Myt1l, and Tbr1), and a "Brn3b-only RGC" group (branch 4, Nhlh1, Eomes, Irx1, and Tbx20). A subset of TFs in branch 3 shows up-regulation in Brn3b AP/KO vs. Brn3b AP/WT RGCs at E15, consistent with their suppression by Brn3b in RGCs (Atoh7, Dlx1, Dlx2, Onecut2, Barhl2, Eya2, and Zic2). Many of these TFs are known to be required upstream or in parallel with Brn3b in the RGC class specification cascade. Similar patterns are seen over the full datasets containing RGC-enriched or Brn3-dependent TFs (Dataset S6 and Fig. S2) . A similar-sized set of TFs is enriched in the retinorecipient areas, with partially overlapping expression between all three nuclei (Fig. 5 F and G, Dataset S6, and Fig. S3 ). The identified sets of TFs and the powerful combinatorics provided by our approach thus yield a large set of potential transcriptional regulators of RGC and/or retinorecipient nuclei cell types.
CSMs Involved in Cell-Cell Interactions, Axon Guidance, and Neurite Formation. A variety of transmembrane proteins involved in cellcell, cell-matrix, and receptor-ligand interactions (e.g., Integrins, Cadherins, Igs, Leucine Rich Repeats, Ephrins, Semaphorins, Plexins, Robo, and Tenneurins) are required for guiding axon and dendrite formation, and/or establishing specific synaptic interactions between neuronal cell types. We, therefore, queried the Gene database (National Center for Biotechnology Information) and established a comprehensive list containing 822 genes that include one or more of these protein domains in their structure. Of these genes, about one-quarter (DESeq = 156, Twofold = 237) were differentially expressed in RGCs ( Fig. 6 A and C and Dataset S7), and an even smaller number (DESeq = 13, Twofold = 93) were regulated by Brn3 TFs in RGCs (Fig. 6 B and D and Dataset S7).
Only very few (DESeq = 20, Twofold = 69) were differentially expressed in retinorecipient areas of the brain (Fig. 6E and Dataset S7). Partially overlapping sets of CSMs were selective for Brn3a and Brn3b (Fig. 6A ) and dynamically expressed during embryonic and early postnatal development in RGCs (Fig. 6C) . The number of differentially regulated transcripts in Brn3b AP RGCs increases between E15 and P3 (Fig. 6D) . A clustergram example of 37 adhesion molecules and/or guidance receptors implicated in RGC development (Fig. 6F ) reveals several interesting patterns. P3 Brn3b AP RGCs are more closely grouped with the retina samples (Fig. 6F , vertical branch d and horizontal branch 1) and share increased expression of several molecules implicated in marking and/or determining lamination in the retina (Jam2, Plxna2, Robo3, Epha8, Sema5a, and Sema5b) (47) (48) (49) (50) . A second group is visibly enriched in E15 Brn3b AP RGCs (Fig. 6F, branch 2 ). Among them, many receptors and/or ligands implicated in axon guidance are enriched in RGCs on Brn3b loss (Sema3a, (Fig. 6F, column 1: compare Brn3b AP/WT with Brn3b AP/KO RGCs) (51-53). Finally, clusters 3 and 4 seem to be highly expressed in most brain regions as well as RGCs at P3. Fig. S4 (Dataset S7) shows the clustergram for all Brn3a-and Brn3b-dependent RGC-enriched transcripts identified in this study. It highlights largely three groups. Branch 1 is P3 RGCspecific and mostly Brn3b-dependent. Branch 2 is specific to E15 Brn3b RGCs and either negatively or positively regulated by Brn3b. Finally, branch 3, by far the largest group, is common to brain regions and P3 RGCs. Most of the molecules in this subgroup are down-regulated in Brn3b AP/KO compared with Brn3b AP/WT RGCs. The extended set of 237 RGC-enriched adhesion molecules (Dataset S7 and Fig. S4 ) follows similar trends. Thus, our screen defines combinatorial expression of many surface ligands and receptors implicated in cell-cell adhesion, neurite formation, and synapse specificity. Brn3b seems to play a role in regulating many of these neuronal identity determinants, thus explaining its important role in axon guidance and dendrite formation, whereas only a few are regulated by Brn3a in keeping Fig. 2E . (I and J) Allen Brain Institute atlas validation outcomes for genes identified in our screen by criteria used in A or B broken down by genes predicted to be expressed only in one retinorecipient nucleus (selective) or expressed at higher levels in two or more retinorecipient nuclei (intersection sets, enriched). From our candidate lists, 122 (LGN), 116 (PTA), and 134 (SC) were present in the Allen Brain Institute atlas, and of those, more than one-half were nucleus-specific for the LGN and SC, but only about one-quarter were nucleus-specific for the PTA. Transcripts in all Venn diagrams and pie charts are listed in Dataset S5.
with its more specific role in RGC type specification. The clustergram of transcripts enriched in retinorecipient areas (Fig. S5 ) reveals clusters specific for three investigated nuclei (LGN, PTA, and SC) that seem to have little expression in the retina or RGCs. However, about 30 transcripts are expressed in RGCs at levels equal to or higher than those in retinorecipient areas. Collectively, the identified CSMs and guidance receptors could represent homoor heterotypic interacting cell-cell adhesion or ligand-receptor pairs involved in targeting the axons of specific RGC types to these nuclei or establishing cognate synaptic connections.
Molecular Determinants of Neuronal Morphology. Dendritic arbor branching patterns of neurons as diverse as RGCs and somatosensory neurons of the peripheral nervous system [dorsal root ganglia (DRG)] bear striking resemblances (6, 40, 54, 55) , despite developing in distinct cellular and extracellular matrix environments. This observation prompted us to ask whether some of our RGC-specific genes could cell-autonomously support process (neurite) extension and branching as proposed in other contexts (56) (57) (58) . To test this possibility, we overexpressed in HEK293 cells a set of 10 candidates identified in our RNASeq data and analyzed the effects on cellular morphology (Fig. 7) . The 10 genes had been confirmed by in situ and belong to molecular families known to affect cellular morphology, but they were relatively unstudied in this context. They range from TFs (Irx4) to cytoskeletal adaptors (Ablim3 and Stmn3), molecules mediating cytoskeleton-membrane interactions [S100a10, copines (Cpne), and Epb4.1l3], membrane folding or trafficking [Reep5 and reticulon receptor 4rl1 (Rtn4rl1)], or putative cell-cell adhesion molecules (Rtn4rl1, PcdhA1, and Igsf) (Fig. 7 and Dataset S8). Target genes were overexpressed using transfection into HEK293-Cre cells using a Cre-dependent FLEX approach (Fig. 7A) (59) . The intracellular localization of the expressed gene can be tracked using its HA tag, whereas a membrane-attached EGFP (meGFP) reveals the effects on cell 50 (11) 18 (10) 41 (23) 16 (5) 45 (26) 19 ( membrane shape (Fig. 7B) . As evident from Fig. 7C , large cellular processes reminiscent of lamellipodia are evident when Stmn3 and Igsf6 are overexpressed, whereas more branched, dendritic-like processes are evident in cells expressing S100a10, Epb4.1l3, Rtn4rl1, or Cpne4, often resulting in a nominal increase of cell area as defined by the bounding polygon (Fig. 7D and Dataset S8). More modest but still significant changes are visible in the case of Irx4, Ablim3, Reep5, or PcdhA1. Thus, isolated overexpression of several molecules identified in our screen may induce morphological changes consistent with neurite formation in cultured epithelial cells.
Subcellular Localization of Candidate Genes in RGCs in Vivo. Consistent with the extensive genetic diversification of molecular families in vertebrates, many of the genes identified in our screen are members of large molecular families. Thus, loss of function screens are not expected to yield dramatic results. However, we studied the subcellular distribution and gain of function effect for some of our candidate molecules by overexpressing them in vivo in RGCs. Cre-dependent adeno-associated virus 1 (AAV1) viral vectors for S100a10, Rtn4rl1, Cpne4, and Igsf6 were injected in the retinas of Brn3b
Cre/WT and Brn3b Cre/Cre mice (60) at P0, and subcellular distribution of the expressed genes together with dendritic arbor morphologies of infected neurons were revealed by immunostaining in adult mice (Fig. 8, Dataset S8, and Fig. S6 ). Although many RGC bodies were meGFP-positive, accurate imaging was possible mostly for the large, sharply laminated dendritic arbor types (characteristic of ON and OFF alpha RGCs). None of the overexpressed molecules induced dramatic changes in dendritic arbor morphologies in either Brn3b
Cre/WT (WT) or Brn3b Cre/Cre (KO) neurons. As an example, dendritic arbor areas of labeled RGCs did not show any changes on either Brn3bCre/Cre (KO) or Brn3bWT/ Cre (WT) RGCs (Fig. 8, Dataset S8, and Fig. S6 ). The subcellular localization of the four molecules varied widely. S100a10, a noncalcium-binding member of the S100 family involved in membrane processes, including signaling and membrane fusion (61, 62) , was restricted to RGC bodies (including the nucleus) and axon ( Fig.  8A and Fig. S6A ). Rtn4rl1 (Nogo receptor 1), implicated in axon navigation across myelinated substrates and endoplasmic reticulum function (63, 64) , is restricted to the cell body and some proximal dendrites (Fig. 8B and Fig. S6B ). Cpne4, a Ca A minimized CMV promoter drives an expression cassette flanked by tandem inverted lox sites (black, loxP; white, lox2272) and followed by a minimized SV40 polyadenylation signal. The expression cassette is in reverse orientation and will be activated by inversion/excision induced by the tandem lox sites (FLEX strategy). It consists sequentially of the cDNA for the gene to be expressed (GeneX), a triple HA tag (HA), a self-cleaving T2A peptide, and EGFP coupled to a GAP43 membrane localization signal (meGFP). ITRs are viral inverted terminal repeats. After Cre-mediated inversion-excision, the two peptides are transcribed and separated on translation; the meGFP reveals the plasma membrane, whereas GeneX distributes in its expected subcellular compartment (e.g., nucleus, intracellular compartment, or plasma membrane) and can be traced by immunostaining with αHA. Cre/WT mice infected at P0 with AAV1 viral vectors for S100a10, Rtn4rl1, Cpne4, and Igsf6 (constructs are in Fig. 7 ). Retinas were whole mount-fixed and immunostained with αHA (red) and αGFP (green). (Upper) Merged image of RGC in flat mount perspective; white marquee squares outline soma and segments of dendritic arbor and axon. Lower shows red, green, and merge channels for the highlighted areas. White arrowheads point to meGFP marking dendrite and axon, and white arrows point to HA-tagged gene localization in dendrite and/or axon. Note that, in D, axons and dendritic arbors of two RGCs are visible, and Igsf6 is localized to the axon arbor of only one of them. (E) Dendritic arbor area measurements for Brn3b
Cre/WT (WT) or Brn3b Cre/Cre (KO) RGCs infected with expression vectors for four genes (Datasets S1 and S2). Box and whiskers plots conventions are the same as in Fig. 7D . Examples for the Brn3b
Cre/Cre (KO) RGC infections are shown in protein with potential synaptic functions (65, 66) was distributed largely in cell bodies (including the nucleus) and dendritic arbors (punctate pattern) and to a lesser extent, axons ( Fig. 8C and Fig.  S6C ). Igsf6, an Ig gene of undefined function, was detectable in dendrite and cell body; however, its axonal distribution seemed to vary from cell to cell (Fig. 8D and Fig. S6D ). These distinct subcellular distributions were confirmed for S100a10, Cpne4, and Igsf6 by staining WT uninfected retinal sections with antibodies against the endogenous proteins (Fig. S6 E-G) . Thus, tissue culture overexpression, subcellular distribution, molecular structure, and previously described functions in other systems collectively point to a role for these molecules in the establishment of neuronal arbor morphology. Because S100a, Cpne, Rtn4r, and Igsf are large molecular families, it is possible that combinatorial expression of one or a few members of these families contributes to the diversification of neuronal arbors. Transcriptional regulation by Brn3 TFs could, therefore, contribute to RGC type specification by driving the selective expression of these downstream targets and hence, inducing distinct features in RGCs.
Discussion
We use RNASeq of purified RGC populations and retina controls to identify combinatorial expression codes for TFs and CSMs proposed to be important for the development and specification of RGC types.
Previously, RGCs have been purified and profiled using immunopanning onto substrates coated with anti-Thy-1 mAb, laser capture microdissection of the GCL, or FACS sorting of genetically labeled GFP-positive neurons (67) (68) (69) (70) (71) . Although immunopanning yields a nearly pure population, it relies on maintaining RGCs in culture for prolonged periods of time, potentially altering expression profile. GCL microdissection (or laser capture) yields fresh cells; however, the sample will contain many amacrine neurons. None of the GFP-labeled lines are limited to RGCs at this point, and relatively small amounts of RGCs are typically collected. Compared with these methodologies, our immunomagnetic purification approach is relatively fast (about 90 min from mouse to freezer or lysis buffer) and has a relatively high recovery rate (about 25% of potential target cells), but it results in less pure samples. RNA profiling involving microarray expression analysis only covers a subset of genes and provides relative gene expression level based on probe hybridization. RNASeq represents the entire collection of transcripts obtained through reverse transcription in a relatively unbiased manner, and each transcript is typically covered by multiple hits. For both approaches, a limiting amount of starting RNA could be an issue, because no matter the depth of sequencing, saturation in number of recovered genes is achieved as recently shown by single-cell RNASeq from retinal populations (72, 73) . In addition, amplification biases could occur early in the amplification process, skewing transcript representation. We, therefore, advocate for validation of RNASeq experiments with ISH or protein detection techniques.
Our dataset confirms between 25 and 50% of the RGCspecific genes previously identified by FACS sorting, immunopanning, or GCL laser capture (67, 68, 71) , with the intersection consisting mostly of well-established RGC markers (Dataset S9 and Fig. S7) . We, however, expand the potential number of targets by an order of magnitude (Dataset S9 and Fig. S7 ). This increase could be caused by the particular comparisons performed in the different screens (e.g., developmental time points of immunopanned RGCs), the purity of the samples (e.g., RGCs vs. Amacrines in the GCL laser capture experiment), the depth of profiling in microarrays vs. RNASeq, or other experimental differences. Expression profiling experiments using microarrays were previously performed on Brn3b KO/KO retinas (74, 75) . Of the combined 234 identified target genes, only 49 are also present in our combined Brn3b regulated dataset comprising 1,008 genes (Dataset S9 and Fig. S7D ). These 49 common genes contain many well-characterized RGC markers and Brn3b target genes. The relative lack of overlap could be explained by (i) dilution of the Brn3b-dependent, RGC-specific genes by the whole retinal tissue or (ii) secondary effects of RGC loss on other retinal precursors.
In our hands, only a small fraction of RGC-enriched transcripts is regulated by Brn3b or Brn3a in RGCs; hence, other TFs may participate in achieving the full RGC phenotype. Of 226 retinal genes affected by Atoh7 loss (76), only 52 where enriched in E15 Brn3b AP/WT RGCs (Dataset S9 and Fig. S7E ). However, from 165 genes enriched in Atoh7 + cells (77) , 120 were also enriched in Brn3b AP/WT RGCs (Dataset S9 and Fig. S7F ). The RGC program may not, therefore, be completely defined by either Atoh7 (Math5) or Pou4f2 (Brn3b), and Atoh7 may be required but may not be sufficient for Brn3b-RGC specification in cell-autonomous and -nonautonomous fashions. Several TFs enriched in Atoh7 
Brn3b
− precursors (Dlx1, Dlx2, Onecut2, and Onecut3) (Dataset S9) are negatively regulated by Brn3b at E15 (Fig. 5H) together with Atoh7 itself. Loss of function phenotypes of these genes include RGC defects linked to defects in Horizontal cells (Onecut), and Amacrines (Dlx) (27, 30, 78, 79) . Among the TFs enriched in Atoh7
+

Brn3b
+ early RGCs and regulated by Atoh7 and Brn3b, some may control specific RGC subtypes (Eomes), whereas others have broader roles in the retina (Onecut1 and Isl1) combined with functions in RGCs (22, 30, 31) . Because negative feedback loops seem to exist between Brn3b, and Atoh7, Dlx, and Onecut (Fig.  5H) , it is possible that Brn3b cooperates with more broadly expressed TFs to define RGCs, while suppressing others (22, 28, 79) . Our previous work suggests that RGC types might be determined by a combination of TF profiles, each encoding distinct features of the RGC type definition. Similar combinatorial codes have been described in the spinal cord of vertebrates, the visual and olfactory systems of flies, and the nervous system of Caenorhabditis elegans (1-3). Our approach enables us to look at the cellautonomous effects of Brn3a and Brn3b loss from RGCs. At least 43 TF genes were differentially expressed in Brn3 KO RGCs compared with the WT controls, a majority in Brn3b. Because these transcripts could indirectly depend on Brn3, say by the modulation of other TFs, ChipSeq analysis would help establish the direct transcriptional relationship. By contrasting Brn3a + , Brn3b + , and Brn3a
+
Brn3b
+ populations, one can gain insights into more narrow RGC subgroups. As an example, Brn3b
RGCs make up Opn4
+ intrinsically photosensitive RGCs (ipRGCs)-positive cells (6, 13, 80) . Here, we show that this subset of RGCs expresses Eomes, Tbox20, and Irx1, consistent with a possible role of these TFs in ipRGC specification (29, 32) . Furthermore, the few genes regulated by Brn3a may be directly relevant to cell type specification of the few cell types missing from Brn3a KO RGCs (5, 13, 31) . The degree of similarity between RGC transcriptional profiles and retina depends on both the developmental age and Brn3 expression status. In several of our clustergrams, Brn3b AP/KO RGCs are segregating together with the retina samples and separated from other RGC populations.
We report a large set of CSMs overexpressed in RGCs compared with the retina. CSMs affected by Brn3 ablation in Brn3 + RGCs are limited in numbers, especially for Brn3a AP RGCs. Thus, very specific candidate genes were identified for the subtle dendritic arbor distinctions in Brn3a AP/KO RGCs. In contrast to the TFs clusters, CSMs seem to more clearly distinguish RGC samples from retina controls (Figs. S4 and S5 ). About 30% of the identified adhesion molecules have already been implicated in various aspects of RGC development, but the separation by Brn3 assignment and the differential expression in Brn3b WT vs. KO RGCs will no doubt help to better target the assignment of individual CSMs to RGC subpopulations. Of particular interest is the negative regulation by Brn3b of a subset of adhesion molecules known to mediate axon guidance decisions (Efna4, Efna5, Efnb2, Epha6, Cntn2, Nfasc, Tenm3, Plxna1, Plxna3, Sema3a, and Slit1) at E15 but not P3. Intriguingly, Brn3b seems to also suppress Zic2 expression in E15 RGCs, a TF required for correct ipsilateral vs. contralateral segregation at the optic chiasm (Fig. 5H) (81) . Many of the disregulated guidance cues function as repellants, potentially explaining the abnormal branching into the inner plexyform layer or nonvisual nuclei of the thalamus observed in Brn3b AP/KO RGC axons. Whole-tissue profiling of retinorecipient nuclei yielded many interesting markers, including some that appeared to be laminated in the SC. Many of the identified TFs confirm previous work on brain patterning; however, the relatively reduced number of differentially expressed adhesion and guidance molecules is somewhat surprising. It could be that RGC axons are triaged during the axon guidance process in the various intermediate points (optic nerve, chiasm, tract, and brachium) and thus, need fewer cues after they have reached the target areas. Alternatively, RGCs may make connections in several nuclei and hence, use similar guidance/recognition codes. Undoubtedly, cell purification, sorting, and profiling approaches using specific markers will distinguish more defined molecular cues. For now, our data provide a useful entry point into the molecular diversity of retinorecipient neurons.
Cell-autonomous mechanisms could determine the shape and size of neuronal arbors. Dissociated cultures of cortical and hippocampal neurons, starburst amacrine cells, and cerebellar Purkinje neurons can adopt morphologies similar to those found in vivo (82) . Our overexpression screen identifies several molecules capable of inducing neurite-like extensions in HEK293 cells. The molecular nature of these genes includes cytoskeleton interactors, transmembrane proteins with roles in intracellular membrane traffic, and membrane-associated molecules with somewhat complex roles in membrane remodeling. Most of the studied genes are members of large molecular families. It is possible that neuronal arbor morphologies could initially be shaped by the combinatorial expression of these genes and then, adjusted and sculpted by negative or positive cues or activity. In some instances, RGCs expressing particularly large amounts of Rtn4rl1, Cpne4, and S100a10 did exhibit changes of the dendritic arbors; however, these defects were rare and inconsistent enough not to be included in this work. However, our expression system allowed us to study the subcellular localization of our candidates in RGCs. It should be noted that subcellular localization of the various candidates could be influenced by RNA processing and trafficking mechanisms, tagging, and/or overexpression and should be confirmed using antibodies against the endogenous protein.
The follow-up and individual investigation of the identified target genes are beyond the scope of this study, but our dataset could benefit a large group of researchers interested in cell type specification, cell surface molecular codes, and pathogenetic mechanisms of glaucoma. The strategy and reagents outlined here could be used to isolate and profile many subpopulations of neurons in the DRG, vestibular and auditory ganglia, and trigeminal ganglia and some sympathetic and parasympathetic afferent neurons, all expressing Brn3s.
Materials and Methods
Mouse lines and genetic recombination strategy were previously described (13) . Retina dissociation was previously described (83) , and immunoaffinity purification was developed by us using magnetic beads coupled to anti-AP antibodies. RGC recovery was tested by AP staining of bead-coupled RGCs and supernatants and estimated to about 25% of all RGCs in a retina, whereas fold enrichment of RGC samples over retinal supernatants was about 65× (Fig. 1F and Dataset S1). Retinorecipient nuclei from WT P3 mice were visualized by anterograde tracing, dissected under a fluorescent microscope, and processed for RNA isolation. The entire remaining brain tissue was homogenized and used as control (Fig. 1E) . RNA extraction was done using the RNEasy Kit (Qiagen), and RNASeq library preparation sequencing on Illumina platforms and Read mapping were previously described (44, 84, 85) . Alignments were visualized with Igviewer (86) . DESeq, hierarchical clustering, and principal components analysis (PCA) were performed using dedicated components of the Matlab Bioinformatics toolbox (42, 87, 88) . Gene Ontology analysis was done using the Panther suite. ISH validation was performed using the protocol described by Schaeren-Wiemers and Gerfin-Moser (89) and queries in the Allen Brain Institute brain atlas. HEK293 overexpression studies, transfections, viral expression vectors, and Brn3-Cre mice AAV infections were previously described. Extensive description of materials and methods is provided in SI Materials and Methods. Mouse handling procedures were approved by the National Eye Institute Animal User Committee under protocol NEI640. Next generation sequencing data reported here are available under Gene Expression Omnibus accession number GSE87647.
